Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 11, November, p. 1581–1585

doi: 10.17219/acem/75676

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Assessment of the FTO gene polymorphisms in male patients with metabolic syndrome

Ryszard Ślęzak1,A,B,C,D,E,F, Przemysław Leszczyński2,B,C,D,F, Magdalena Warzecha1,B,C,F, Łukasz Łaczmański3,C,D,E,F, Błażej Misiak1,A,C,D,E,F

1 Department of Genetics, Wroclaw Medical University, Poland

2 Department of Biology and Medical Parasitology, Wroclaw Medical University, Poland

3 The Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wrocław, Poland

Abstract

Background. Accumulating evidence indicates the potential involvement of the FTO gene polymorphisms in the etiology of metabolic syndrome (MetS) and related disorders.
Objectives. In this study, we aimed to investigate whether the FTO gene polymorphisms are associated with the risk of MetS and its simple components in a homogeneous sample of males.
Material and Methods. Anthropometric and biochemical parameters were assessed in 192 males. A total of 100 males met the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria for a diagnosis of MetS. The following FTO gene polymorphisms were genotyped: rs1421085, rs17817449, rs1558902, and rs9939609.
Results. There were significant differences between participants with distinct rs9939609 genotypes with respect to waist-to-hip ratio (WHR) and the levels of total cholesterol. Individuals with the rs1421085 CC genotype had significantly higher levels of triglycerides compared to those with other corresponding genotypes. Participants with the rs1558902 AA genotype had significantly higher body mass index (BMI), WHR, as well as the levels of total cholesterol and triglycerides. There were no significant differences in genotype distribution allelic frequencies of all tested polymorphisms between individuals with MetS and control subjects.
Conclusion. Our results indicate that the genetic variation in the FTO gene might be related to single metabolic disturbances. However, the FTO gene polymorphisms are not associated with the risk of MetS.

Key words

metabolic syndrome, obesity, polymorphism, FTO gene

References (27)

  1. Hanson M, Gluckman P, Bustreo F. Obesity and the health of future generations. Lancet Diabetes Endocrinol. 2016;4(12):966–967.
  2. Wang H, Dong S, Xu H, Qian J, Yang J. Genetic variants in FTO associated with metabolic syndrome: A meta- and gene-based analysis. Mol Biol Rep. 2012;39:5691–5698.
  3. de Luis DA, Aller R, Conde R, Izaola O, de la Fuente B, Sagrado MG. Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients. J Diabetes Complications. 2013;27: 346–350.
  4. Elouej S, Nagara M, Attaoua R, et al. Association of genetic variants in the FTO gene with metabolic syndrome: A case-control study in the Tunisian population. J Diabetes Complications. 2016;30:206–211.
  5. Hu YH, Liu JM, Zhang M, et al. Association between polymorphisms of fat mass and obesity-associated gene and metabolic syndrome in Kazakh adults of Xinjiang, China. Genet Mol Res. 2015;14:14597–14606.
  6. Kawajiri T, Osaki Y, Kishimoto T. Association of gene polymorphism of the fat mass and obesity associated gene with metabolic syndrome: A retrospective cohort study in Japanese workers. Yonago Acta Med. 2012;55:29–40.
  7. Liguori R, Labruna G, Alfieri A, Martone D, Farinaro E, Contaldo F. The FTO gene polymorphism (rs9939609) is associated with metabolic syndrome in morbidly obese subjects from southern Italy. Mol Cell Probes. 2014;28:195–199.
  8. Yang J, Liu J, Li W, Li X, He Y, Ye L. Genetic association study with metabolic syndrome and metabolic-related traits in a cross-sectional sample and a 10-year longitudinal sample of Chinese elderly population. PLoS ONE. 2014;9:e100548.
  9. Zhou D, Liu H, Zhou M, et al. Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol Biol Rep. 2012;39: 6555–6561.
  10. Merkestein M, Sellayah D. Role of FTO in adipocyte development and function: Recent insights. Int J Endocrinol. 2015; Article ID 521381.
  11. Tung YC, Yeo GS, O’Rahilly S, Coll AP. Obesity and FTO: Changing focus at a complex locus. Cell Metab. 2014;20:710–718.
  12. Saldana-Alvarez Y, Salas-Martinez MG, Garcia-Ortiz H, et al. Gender-dependent association of FTO polymorphisms with body mass index in Mexicans. PLoS ONE. 2016;11:e0145984.
  13. Hubacek JA, Pitha J, Adamkova V, Lanska V, Poledne R. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies. Clin Chem Lab Med. 2009;47: 387–390.
  14. Wu Q, Saunders RA, Szkudlarek-Mikho M, Serna Ide L, Chin KV. The obesity-associated FTO gene is a transcriptional coactivator. Biochem Biophys Res Commun. 2010;401:390–395.
  15. Yeo GS, O’Rahilly S. Uncovering the biology of FTO. Mol Metab. 2012; 1(1–2):32–36.
  16. Fawcett KA, Barroso I. The genetics of obesity: FTO leads the way. Trends Genet. 2010;26(6):266–274.
  17. Zhang Z, Zhou D, Lai Y, Liu Y, Tao X, Wang Q. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways. Cancer Lett. 2012;319:89–97.
  18. Binh TQ, Phuong PT, Nhung BT, Thoang DD, Lien HT, Thanh DV. Association of the common FTO-rs9939609 polymorphism with type 2 diabetes, independent of obesity-related traits in a Vietnamese population. Gene. 2013;513(1):31–35.
  19. Dusatkova L, Zamrazilova H, Sedlackova B, Vcelak J, Hlavaty P, Aldhoon Hainerova I. Association of obesity susceptibility gene variants with metabolic syndrome and related traits in 1,443 Czech adolescents. Folia Biol (Praha). 2013;59(3):123–133.
  20. Hunt SC, Stone S, Xin Y, Scherer CA, Magness CL, Iadonato SP. Association of the FTO gene with BMI. Obesity (Silver Spring). 2008;16:902–904.
  21. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genetics. 2007;3:e115.
  22. Al-Attar SA, Pollex RL, Ban MR, et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc Diabetol. 2008;7:5.
  23. Karaderi T, Drong AW, Lindgren CM. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of obesity-related traits. Curr Diab Rep. 2015;15:83.
  24. Liu C, Mou S, Pan C. The FTO gene rs9939609 polymorphism predicts risk of cardiovascular disease: A systematic review and meta-analysis. PLoS ONE. 2013;8:e71901.
  25. Freathy RM, Timpson NJ, Lawlor DA, et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes. 2008;57:1419–1426.
  26. Hotta, K, Nakata Y, Matsuo T, et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet. 2008;53: 546–553.
  27. Harbron J, van der Merwe L, Zaahl MG, Kotze MJ, Senekal M. Fat mass and obesity-associated (FTO) gene polymorphisms are associated with physical activity, food intake, eating behaviors, psychological health, and modeled change in body mass index in oveweight/obese Caucasian adults. Nutrients. 2014;6(8):3130–3152.
© Wroclaw Medical University